[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
December 21, 2011

USPSTF Finds Little Evidence to Support Advising PSA Screening in Any Man

JAMA. 2011;306(23):2549-2551. doi:10.1001/jama.2011.1804

The recommendation by the US Preventive Services Task Force (USPSTF) in October that no man receive prostate-specific antigen (PSA)–based screening for prostate cancer was as welcomed by primary care physicians as it was denounced by many urologists.

Now, “I probably won't be entering a discussion about prostate cancer screening unless my patient has a family history of prostate cancer or he expresses concern,” said general internist Christine Laine, MD, MPH, editor in chief of Annals of Internal Medicine, which published the USPSTF draft recommendation (http://www.annals.org/content/early/2011/10/07/0003-4819-155-11-201112060-00375.1.full). That frees up time to focus on the “million other things we have to cover at each patient visit,” she said.